Search by Drug Name or NDC
NDC 00456-2700-10 AVYCAZ .5; 2 g/1; g/1 Details
AVYCAZ .5; 2 g/1; g/1
AVYCAZ is a INTRAVENOUS POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is AVIBACTAM SODIUM; CEFTAZIDIME.
MedlinePlus Drug Summary
The combination of ceftazidime and avibactam injection is used with metronidazole (Flagyl) to treat abdominal (stomach area) infections. It is also used to treat pneumonia that developed in people who are on ventilators or who were in a hospital, and kidney and urinary tract infections. Ceftazidime is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Avibactam is in a class of medications called beta-lactamase inhibitors. It works by preventing bacteria from breaking down ceftazidime. Antibiotics such as ceftazidime and avibactam will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00456-2700-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ceftazidime and Avibactam Injection
Product Information
| NDC | 00456-2700 |
|---|---|
| Product ID | 0456-2700_3873fe44-7870-4d3e-9a4f-e94b402d7762 |
| Associated GPIs | 02990002332120 |
| GCN Sequence Number | 073580 |
| GCN Sequence Number Description | ceftazidime/avibactam VIAL 2.5 G INTRAVEN |
| HIC3 | W1Y |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION |
| GCN | 38002 |
| HICL Sequence Number | 041790 |
| HICL Sequence Number Description | CEFTAZIDIME/AVIBACTAM SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | AVYCAZ |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ceftazidime, avibactam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | .5; 2 |
| Active Ingredient Units | g/1; g/1 |
| Substance Name | AVIBACTAM SODIUM; CEFTAZIDIME |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA206494 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00456-2700-10 (00456270010)
| NDC Package Code | 0456-2700-10 |
|---|---|
| Billing NDC | 00456270010 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0456-2700-10) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0456-2700-01) |
| Marketing Start Date | 2014-12-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |